RXO: Barclays Raises Target
Barclays analyst Brandon Oglenski raises RXO price target to $28 and maintains Overweight rating
Barclays analyst Brandon Oglenski maintains RXO (NYSE: RXO ) with a Overweight and raises the price target from $20 to $28.
Barclays analyst Brandon Oglenski raises RXO price target to $28 and maintains Overweight rating
Barclays analyst Brandon Oglenski maintains RXO (NYSE: RXO ) with a Overweight and raises the price target from $20 to $28.